Gilead Sciences Inc (GILD)
67.72
-0.14
(-0.21%)
USD |
NASDAQ |
May 17, 16:00
67.59
-0.13
(-0.19%)
After-Hours: 07:00
Gilead Sciences Cash from Operations (Annual): 8.006B for Dec. 31, 2023
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.006B |
| December 31, 2022 | 9.072B |
| December 31, 2021 | 11.38B |
| December 31, 2020 | 8.168B |
| December 31, 2019 | 9.144B |
| December 31, 2018 | 8.40B |
| December 31, 2017 | 11.90B |
| December 31, 2016 | 17.05B |
| December 31, 2015 | 21.25B |
| December 31, 2014 | 12.82B |
| December 31, 2013 | 3.105B |
| December 31, 2012 | 3.195B |
| December 31, 2011 | 3.639B |
| December 31, 2010 | 2.834B |
| December 31, 2009 | 3.080B |
| December 31, 2008 | 2.143B |
| December 31, 2007 | 1.765B |
| Date | Value |
|---|---|
| December 31, 2006 | 1.218B |
| December 31, 2005 | 705.64M |
| December 31, 2004 | 507.96M |
| December 31, 2003 | 234.61M |
| December 31, 2002 | 74.41M |
| December 31, 2001 | -126.98M |
| December 31, 2000 | -38.20M |
| December 31, 1999 | -62.60M |
| December 31, 1998 | -51.30M |
| December 31, 1997 | -54.50M |
| December 31, 1996 | -16.50M |
| December 31, 1995 | -23.00M |
| March 31, 1995 | -27.40M |
| March 31, 1994 | -22.40M |
| March 31, 1993 | -8.90M |
| March 31, 1992 | -3.70M |
| March 31, 1991 | -2.40M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Annual) Range, Past 5 Years
8.006B
Minimum
2023
11.38B
Maximum
2021
9.155B
Average
9.072B
Median
2022
Cash from Operations (Annual) Benchmarks
| Bristol-Myers Squibb Co | 13.86B |
| Merck & Co Inc | 13.01B |
| Pfizer Inc | 8.70B |
| AbbVie Inc | 22.84B |
| Xilio Therapeutics Inc | -68.62M |